Advertisement

A New Diphosphonate: Dissociation Between Effects on Cells and Mineral in Rats and a Preliminary Trial in Paget’s Disease

  • H. H. P. J. Lemkes
  • P. H. Reitsma
  • W. Frijlink
  • H. Verlinden-Ooms
  • Olav L. M. Bijvoet
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 103)

Abstract

Diphosphonates are of pharmacological interest because they act on bone (1). In animals they decrease the performance of osteoclasts and of osteoblasts and can hinder the mineralization of osteoid (2,3,4). The first two properties have been used to reduce bone turnover in patients with Paget’s disease by treatment with Ethane-l-hydroxy-1,1-diphosphonate (EHDP) (5). But, whilst the desired decrement of activity of the disease was often achieved, the hindrance of mineralization has caused excesse of unmineralized osteoid in the diseased bones (6). This is probably why patients treated with EHDP have had an increased incidence of pathological fractures (7,8,9). Is undermineralization a necessary price to pay for reduction of bone formation and resorption in Paget’s disease by diphosphonates?

Keywords

Bone Formation Bone Resorption Calcium Uptake Lactate Production Calcify Cartilage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Russell, R.G.G. and Fleisch, H.: Pyrophosphate and diphosphonates in skeletal metabolism. Clin.Orthop.Rel.Res. 108: 241, 1975.CrossRefGoogle Scholar
  2. 2.
    Miller, S.C. and Jee, W.S.S.: The comparative effects of dichloromethylene diphosphonate (C12MDP) and ethane-1-hydroxy-1,1diphosphonate (EHDP) on growth and modeling of the rat tibia. Calc.Tiss.Res. 23: 207, 1977.CrossRefGoogle Scholar
  3. 3.
    Russell, R.G.G., Kislig, A.M., Casey, P.A., Fleisch, H., Thornton, J., Schenk, R. and Williams, D.A.: Effect of diphosphonates and calcitonin on the chemistry and quantitative histology of rat bone. Calc.Tiss.Res. 11: 179, 1973.CrossRefGoogle Scholar
  4. 4.
    Schenk, R., Merz, W.A., Miihlbauer, R., Russell, R.G.G. and Fleisch, H.: Effect of ethane-l-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (C12MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calc.Tiss.Res. 11: 196, 1973.CrossRefGoogle Scholar
  5. 5.
    Smith, R., Russell, R.G.G., Bishop, M.C., Woods, C.G. and Bishop, M.: Paget’s disease of bone: Experience with a diphosphonate (disodium etidronate) in treatment. Quart.Med. 42: 235, 1973.Google Scholar
  6. 6.
    Russell, R.G.G., Smith, R., Preston, C., Walton, R.J. and Woods, C.G.: Diphosphonates in Paget’s disease. Lancet (i): 894, 1974.Google Scholar
  7. 7.
    Fromm, G., Schajowicz, F. and Mautalen, C.A.: Disodium ethane1-hydroxy-1,1-diphosphonate in Paget’s disease. Lancet (ii): 666, 1975.CrossRefGoogle Scholar
  8. 8.
    Reiker, M., Jong, A., Seiler, A., Schenk, R. and Fleisch, H.: Le traitement de la maladie de Paget par les diphosphonates. Schweiz.med.Wschr. 105: 1701, 1975.Google Scholar
  9. 9.
    Finerman, G.A.M., Gronick, H.G., Smith, R.K., and Mayfield, J. Diphosphonate treatment of Paget’s disease. Clin.Orthop. 120: 115, 1976.PubMedGoogle Scholar
  10. 10.
    Wuthier, R.E.: A zonal analysis of inorganic and organic constituents of the epiphysis during enchondral calcification. Calc.Tiss.Res. 4: 20, 1969.CrossRefGoogle Scholar
  11. 11.
    Russell, R.G.G. and Smith, R.: Diphosphonates - Experimental and clinical aspects. J.Bone Joint Surg.(Br) 55B: 66, 1973.Google Scholar
  12. 12.
    Wöltgens, J.H.M., Bonting, S.L. and Bijvoet, O.L.M.: Inorganic pyrophosphatase in mineralizing hamster molars. III. Influence of diphosphonates. Calc.Tiss.Res. 13: 151, 1973.CrossRefGoogle Scholar
  13. 13.
    Bijvoet, O.L.M., Hosking, D.J., Lemkes, H.H.P.J., Reitsma, P.H. and Frijlink, W.: Development in the treatment of Paget’s disease. To be published in: Proceedings of the Vth Parathyroid conference 1977. Elsevier, Amsterdam.Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • H. H. P. J. Lemkes
    • 1
  • P. H. Reitsma
    • 1
  • W. Frijlink
    • 1
  • H. Verlinden-Ooms
    • 1
  • Olav L. M. Bijvoet
    • 1
  1. 1.Metabolic Unit, Dept. of Endocrinology and MetabolismUniversity HospitalLeidenThe Netherlands

Personalised recommendations